Because it sounds so obviously logical, policymakers and payers have been quick to adopt and enforce various pay-for-performance and quality reporting schemes, often ignoring warnings about design and operational issues. A report from the Urban Institute details concerns about such programs and offers suggestions for a path to improving them. (Urban Inst. Report) The goal of quality reporting and incentive programs is quality improvement, yet the evaluations of most of these programs show very little if any progress on that goal to date. This may be because the programs tend to focus on process measures which may have little to do with real health outcomes, but are easier to collect data on. One big problem with these programs is that they are disruptive and expensive to comply with, and they may hinder a clinician’s sense of autonomy and motivation. The authors detail the problems and concerns and then give seven well-thought out recommendations for improving quality reporting, pay-for-performance and value-based purchasing programs: move from measuring process to directly measuring outcomes; don’t rely solely on these programs for quality improvement but use them only where other approaches may not work; measure quality at an organizational level, not that of the individual clinician; measure patient experience and patient-reported outcomes as their own ends; promote rapid-learning through the programs; develop the science of measurement better, especially to avoid unintended consequences; and have only one entity developing measures and standards.
✅ Subscribe via Email
About this Blog
The Healthy Skeptic is a website about the health care system, and is written by Kevin Roche, who has many years of experience working in the health industry. Mr. Roche is available to assist health care companies through consulting arrangements through Roche Consulting, LLC and may be reached at [email protected].
Healthy Skeptic Podcast
This is an outstanding report on total global drug spending and trends, with projections out to 2025. It helps you understand this important area of health care, which does much...
June 1, 2021
MedPAC 2019 Report to Congress
June 18, 2019
IBM ending a huge bust in its health care efforts, selling its Watson health care assets to a PE firm. IBM spent a fortune building this and claimed it would...
January 21, 2022
More lunacy, kind of ironic for a mental health company, as Lyra Health raises a fresh $235 million in capital at over a $5 billion valuation. Just gonna say the...
January 20, 2022
More froth in the capital markets as R1 RCM pays $4.1 billion for CloudMed. R1 RCM helps health care providers with billing and other practice management software and services and...
January 12, 2022
Access ACO Care Management Chronic Disease Comparative Effectiveness Consumer Directed Health Consumers Devices Disease Management Drugs EHRs Elder Care End-of-Life Care FDA Financings Genomics Government Health Care Costs Health Care Quality Health Care Reform Health Insurance Health Insurance Exchange HIT HomeCare Hospital Hospital Readmissions Legislation M&A Malpractice Meaningful Use Medicaid Medical Care Medicare Medicare Advantage Mobile Pay For Performance Pharmaceutical Physicians Providers Regulation Repealing Reform Telehealth Telemedicine Wellness and Prevention Workplace